[Present Situation Regarding Development of an HIV Vaccine]

Enferm Infecc Microbiol Clin. 2002 Dec;20(10):511-22. doi: 10.1016/s0213-005x(02)72855-3.
[Article in Spanish]

Abstract

The AIDS epidemic continues to advance, and the development of a preventive HIV vaccine has become a major objective for scientific research. An effective vaccine against this virus is not available and complete protection still has not been achieved in animal models. In this review the major challenges related to the development of a vaccine against HIV are analyzed, particularly the mechanisms involved in viral escape from the immune response, and the results obtained with the various therapeutic and preventive vaccine prototypes are summarized. Finally, the social, economic and health aspects related to research on HIV vaccines and the current controversy around the performance of clinical trials with these agents is discussed.

Publication types

  • English Abstract
  • Review

MeSH terms

  • AIDS Vaccines / biosynthesis
  • AIDS Vaccines / therapeutic use*
  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / prevention & control*
  • Antibody Formation / immunology
  • Antibody Formation / physiology
  • Clinical Trials as Topic / ethics
  • Epitopes
  • Humans
  • Immunity, Cellular / immunology
  • Immunity, Cellular / physiology
  • Vaccines, Attenuated / biosynthesis
  • Vaccines, Attenuated / immunology
  • Vaccines, Attenuated / therapeutic use
  • Vaccines, DNA / immunology
  • Vaccines, Inactivated / biosynthesis
  • Vaccines, Inactivated / immunology
  • Vaccines, Inactivated / therapeutic use
  • Viral Proteins / immunology

Substances

  • AIDS Vaccines
  • Epitopes
  • Vaccines, Attenuated
  • Vaccines, DNA
  • Vaccines, Inactivated
  • Viral Proteins